CC BY-NC-ND 4.0 · AJP Rep 2019; 09(03): e226-e234
DOI: 10.1055/s-0039-1693163
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Association of Bacterial Vaginosis with Vitamin D in Pregnancy: Secondary Analysis from the Kellogg Pregnancy Study

Anna Maya Powell
1   Department of Gynecology and Obstetrics, Johns Hopkins Bayview Medical Center, Baltimore, Maryland
,
Judy R. Shary
2   Division of Neonatology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina
,
Christopher Louden
3   Louden Consulting, Bandera, Texas
,
Vishwanathan Ramakrishnan
4   Department of Biostatistics, Medical University of South Carolina, Charleston, South Carolina
,
Allison Ross Eckard
5   Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina
,
Carol L. Wagner
2   Division of Neonatology, Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina
› Author Affiliations
Funding Funded by the W. K. Kellogg Foundation and by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, NIH/NCAT grant number UL1 TR000062. Vitamin D study drug and placebo provided by Church & Dwight (Princeton, NJ).
Further Information

Publication History

22 January 2019

26 April 2019

Publication Date:
11 July 2019 (online)

Abstract

Objective Bacterial vaginosis (BV) is associated with vitamin D deficiency and poor pregnancy outcomes. We studied a nested cohort from a randomized controlled trial to investigate the association between BV and vitamin D concentration in pregnancy.

Study Design Subjects with randomly assigned 400 versus 4,400 IU of daily cholecalciferol (vitamin D3) had vaginal swabs collected for Gram staining and Nugent score calculation, as well as plasma 25-hydroxyvitamin D (25(OH)D) measurement at three pregnancy time points.

Results Fifty-two (21.2%) of the 245 women included in the analysis were diagnosed with BV at study entry. Women with BV were also more likely to be African American (p < 0.0001) and have lower 25(OH)D concentrations at 22 to 24 weeks' gestation (p = 0.03). There were no differences in pregnancy outcomes of interest within this group compared with the remaining study subjects. In mixed regression modeling, while race (p = 0.001) and age (p = 0.03) were significant predictors of BV prevalence independently, 25(OH)D concentration (p = 0.81), gestational age (p = 0.06), and body mass index (p = 0.87) were not.

Conclusion Neither vitamin D deficiency in early pregnancy nor supplementation decreased BV incidence during pregnancy. Pregnancy outcomes (preterm birth and hypertensive disorders of pregnancy) were similar among women with and without BV.

Note

This study was presented at the annual Infectious Disease Society for Obstetricians and Gynecologists in Park City, UT, August 2017.


Disclosure

The authors have no relevant financial disclosure.


 
  • References

  • 1 Aranow C. Vitamin D and the immune system. J Investig Med 2011; 59 (06) 881-886
  • 2 Tamblyn JA, Hewison M, Wagner CL, Bulmer JN, Kilby MD. Immunological role of vitamin D at the maternal-fetal interface. J Endocrinol 2015; 224 (03) R107-R121
  • 3 National Institutes of Health OoDS. Vitamin D: Fact Sheet for Health Professionals. 2016 . Available at: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ . Accessed December 11, 2018
  • 4 Ginde AA, Sullivan AF, Mansbach JM, Camargo Jr CA. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol 2010; 202 (05) 436.e1-436.e8
  • 5 Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169 (06) 626-632
  • 6 Amegah AK, Klevor MK, Wagner CL. Maternal vitamin D insufficiency and risk of adverse pregnancy and birth outcomes: a systematic review and meta-analysis of longitudinal studies. PLoS One 2017; 12 (03) e0173605
  • 7 Wagner CL, Baggerly C, McDonnell S. , et al. Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009-2011 rates. J Steroid Biochem Mol Biol 2016; 155 (Pt B): 245-251
  • 8 Wei SQ, Qi HP, Luo ZC, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2013; 26 (09) 889-899
  • 9 Weinert LS, Reichelt AJ, Schmitt LR. , et al. Vitamin D deficiency increases the risk of adverse neonatal outcomes in gestational diabetes. PLoS One 2016; 11 (10) e0164999
  • 10 Dawodu A, Saadi HF, Bekdache G, Javed Y, Altaye M, Hollis BW. Randomized controlled trial (RCT) of vitamin D supplementation in pregnancy in a population with endemic vitamin D deficiency. J Clin Endocrinol Metab 2013; 98 (06) 2337-2346
  • 11 McDonnell SL, Baggerly KA, Baggerly CA. , et al. Maternal 25(OH)D concentrations ≥ 40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center. PLoS One 2017; 12 (07) e0180483
  • 12 Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 2013; 92 (02) 128-139
  • 13 Mitchell C, Marrazzo J. Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol 2014; 71 (06) 555-563
  • 14 Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994; 308 (6924): 295-298
  • 15 Qin LL, Lu FG, Yang SH, Xu HL, Luo BA. Does maternal vitamin D deficiency increase the risk of preterm birth: a meta-analysis of observational studies. Nutrients 2016; 8 (05) E301
  • 16 Bodnar LM, Platt RW, Simhan HN. Early-pregnancy vitamin D deficiency and risk of preterm birth subtypes. Obstet Gynecol 2015; 125 (02) 439-447
  • 17 Jacobsson B, Pernevi P, Chidekel L, Jörgen Platz-Christensen J. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand 2002; 81 (11) 1006-1010
  • 18 Murphy K, Mitchell CM. The interplay of host immunity, environment and the risk of bacterial vaginosis and associated reproductive health outcomes. J Infect Dis 2016; 214 (Suppl. 01) S29-S35
  • 19 Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003; 37 (03) 319-325
  • 20 Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003; 36 (05) 663-668
  • 21 Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr 2009; 139 (06) 1157-1161
  • 22 Davis LM, Chang SC, Mancini J, Nathanson MS, Witter FR, O'Brien KO. Vitamin D insufficiency is prevalent among pregnant African American adolescents. J Pediatr Adolesc Gynecol 2010; 23 (01) 45-52
  • 23 Dunlop AL, Taylor RN, Tangpricha V, Fortunato S, Menon R. Maternal vitamin D, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy. Infect Dis Obstet Gynecol 2011; 2011: 216217
  • 24 Turner AN, Carr Reese P, Chen PL. , et al. Serum vitamin D status and bacterial vaginosis prevalence and incidence in Zimbabwean women. Am J Obstet Gynecol 2016; 215 (03) 332.e1-332.e10
  • 25 Turner AN, Carr Reese P, Fields KS. , et al. A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. Am J Obstet Gynecol 2014; 211 (05) 479.e1-479.e13
  • 26 Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26 (10) 2341-2357
  • 27 Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29 (02) 297-301
  • 28 Taheri M, Baheiraei A, Foroushani AR, Nikmanesh B, Modarres M. Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: a placebo-controlled randomized clinical trial. Indian J Med Res 2015; 141 (06) 799-806
  • 29 Cole AM, Cole AL. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reprod Immunol 2008; 59 (01) 27-34
  • 30 Balkus J, Agnew K, Lawler R, Mitchell C, Hitti J. Effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions. J Pregnancy 2010; 2010: 385981
  • 31 Ferreira CS, Marconi C, Parada CM. , et al. Bacterial vaginosis in pregnant adolescents: proinflammatory cytokine and bacterial sialidase profile. Cross-sectional study. Sao Paulo Med J 2015; 133 (06) 465-470
  • 32 Valore EV, Wiley DJ, Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 2006; 74 (10) 5693-5702
  • 33 Jin D, Wu S, Zhang YG. , et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther 2015; 37 (05) 996-1009.e7